Trial · NCT02879448
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Primary Safety Endpoint: Composite Endpoint Rate of Procedure-related Complications, or All-cause Death or Major Bleeding (Defined as Type 3 or Greater Based on the Bleeding Academic Research Consortium (BARC) Definition) (Non-inferiority Analysis) | At 12-months | The number of participants analyzed includes subjects who were available at that time of analysis | Percentage of participants | NUMBER |
| PRIMARY | Primary Effectiveness Endpoint: Composite Rate of Ischemic Stroke or Systemic Embolism (Non-inferiority Analysis) | At 18-months | The number of participants analyzed includes subjects who were available at that time of analysis | Percentage of participants | NUMBER |
| PRIMARY | Mechanism of Action Primary Endpoint: Rate of Device Closure, by the Echocardiography Core Lab (Non-inferiority Analysis) | At 45-days | The number of participants analyzed includes subjects who were available at that time of analysis | Percentage of participants | NUMBER |
| SECONDARY | Composite Rate of All Stroke, Systemic Embolism, or Cardiovascular/Unexplained Death (Non-inferiority Analysis) | At 18-months | The number of participants analyzed includes subjects who were available at that time of analysis | Percentage of participants | NUMBER |
| SECONDARY | Rate of Major Bleeding (Superiority Analysis) | At 18-months | The number of participants analyzed includes subjects who were available at that time of analysis | Percentage of participants | NUMBER |
| SECONDARY | Superiority Test of Primary Safety Endpoint: Composite Endpoint Rate of Procedure-related Complications, or All-cause Death or Major Bleeding (Defined as Type 3 or Greater Based on the Bleeding Academic Research Consortium (BARC) Definition) | At 12-months | The number of participants analyzed includes subjects who were available at that time of analysis | percentage of participants | NUMBER |
| SECONDARY | Superiority Test of Primary Effectiveness Endpoint: Composite Rate of Ischemic Stroke or Systemic Embolism | At 18-months | The number of participants analyzed includes subjects who were available at that time of analysis | Percentage of participants | NUMBER |
| SECONDARY | Superiority Test of Primary Mechanism of Action Endpoint: Rate of Device Closure, by the Echocardiography Core Lab | At 45-days | The number of participants analyzed includes subjects who were available at that time of analysis | Percentage of participants | NUMBER |
| POST_HOC | Composite Rate of Ischemic Stroke and Systemic Embolism | 5 Years | Analysis included subjects who underwent an implant attempt regardless of the device attempted or implanted. | percentage of participants | NUMBER |
| POST_HOC | Composite Rate of Stroke, Systemic Embolism, or CV/Unexplained Death | 5 Years | Analysis included subjects who underwent an implant attempt regardless of the device attempted or implanted. | percentage of participants | NUMBER |
| POST_HOC | Rate of Major Bleeding | 5 Years | Analysis included subjects who underwent an implant attempt regardless of the device attempted or implanted. | percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02879448/outcomes